Cardiol Therapeutics Inc. (TSE:CRDL - Get Free Report)'s stock price shot up 1% during trading on Friday . The company traded as high as C$2.08 and last traded at C$2.07. 77,015 shares were traded during trading, an increase of 6% from the average session volume of 72,656 shares. The stock had previously closed at C$2.05.
Cardiol Therapeutics Trading Up 1.0%
The firm has a market capitalization of C$171.77 million, a PE ratio of -4.07 and a beta of 0.70. The stock's 50-day moving average price is C$1.73 and its 200 day moving average price is C$1.70. The company has a debt-to-equity ratio of 1.59, a current ratio of 2.49 and a quick ratio of 6.84.
Cardiol Therapeutics Company Profile
(
Get Free Report)
Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis.
Featured Stories
Before you consider Cardiol Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardiol Therapeutics wasn't on the list.
While Cardiol Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
